Metraipolis › archive › dc_39b1f163dcef

Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41132193
DOI
10.1002/hsr2.71388
License (as archived)
solo-consultazione
Archived
2026-11-09T04:22:04.137Z
SHA-256 of the archived text
f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49
Stable URL of this page
https://metraipolis.com/documento/dc_39b1f163dcef

How to cite

Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193 — Europe PMC (en), https://europepmc.org/article/MED/41132193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_39b1f163dcef (Metraipolis archive dc_39b1f163dcef, sha256 f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49)
BibTeX
@misc{dc39b1f163dcef,
  title = {Efficacy of DMARDs Therapy on the Disease Activity and Gene Expression Levels of FoxO1, FoxO3, Runx1, and Runx3 in Early Rheumatoid Arthritis Patients: A… — Europe PMC PMID:41132193},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41132193},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_39b1f163dcef; sha256 f7689ff33f30456444d1e236f2311198139c68f703fd5bfa085afacdb23d5b49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41132193. Agents can read the archived copy with the MCP tool read_document.